JPRN-UMIN000051300尚未招募Unknown
Ensitrelvir Fumaric Acid in Patients with SARS-CoV-2 - Retrospective Chart Review - - Ensitrelvir Fumaric Acid in Patients with SARS-CoV-2 - Retrospective Chart Review
Shionogi & Co., Ltd.0 个研究点目标入组 52 人开始时间: 2023年6月9日最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
- 入组人数
- 52
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who meet any of the following criteria are excluded from the study. 1) Patients who were treated "off-label" 2) Patients who refuse to participate in this study
研究者
相似试验
进行中（未招募）
Unknown
ensitrelvir in patients with SARS-CoV-2 infection; a randomized, open-label, molnupiravir-controlled studyJPRN-jRCTs071230014Mukae Hiroshi150
招募中
Unknown
Copmarison of ensitrelvir and nirmatrelvir/ritonavirCOVID-19C01.748.610.763.500JPRN-jRCT1031230005Yoshimura Yukihiro360
已完成
不适用
Effect of antiviral therapy in patients with acute respiratory distress syndrome after CAP (community acquired pneumonia) and H1N1 infection on health-related quality of life (HRQoL) and cognitive performanceacute respiratory distress syndromeJ80Adult respiratory distress syndromeDRKS00011913Charité Universitätsmedizin Berlin Klinik für Anästhesiologie m. S. Intensivmedizin Campus Benjamin Franklin42
已完成
1 期
Efficacy of Daclatasvir+Sofosbuvir in patients with severe acute respiratory syndrome coronavirus (SARS-COVID-19)IRCT20200816048422N1Ahvaz University of Medical Sciences70
进行中（未招募）
1 期
Hydroxychloroquine as a treatment for coronavirus disease COVID-19EUCTR2020-000890-25-FRFondation Méditerranée Infection (FMI) - IHU Méditerranée Infection25